Home › NCT06155643

EKO SENSORA: Detecting Clinically Significant Murmurs

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope.
* Patients with chief complaint of Weakness would be eligible if over the age of 50 and have a history of at least two of hypertension, BMI\>/= 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/Transient ischemic attack, prior cardiac surgery or angiography

Exclusion Criteria:

* Contact isolation patients
* Pediatric patients under the age of 18

About the study

The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023).

The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction.

The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.

What is being tested

• Eko Sensora (device)

Sponsor: Corewell Health South · Participants: 300 · Started: Oct 26, 2023

Contact the study team

• Monique Luna, MS · Phone: 2699838679

Official record on ClinicalTrials.gov — NCT06155643

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.